Ad is loading...
BDSX
Price
$1.34
Change
-$0.05 (-3.57%)
Updated
Nov 15 closing price
120 days until earnings call
KSRBF
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
Ad is loading...

BDSX vs KSRBF

Header iconBDSX vs KSRBF Comparison
Open Charts BDSX vs KSRBFBanner chart's image
Biodesix
Price$1.34
Change-$0.05 (-3.57%)
Volume$482.91K
CapitalizationN/A
Kossan Rubber Industries
Price$0.27
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
BDSX vs KSRBF Comparison Chart
Loading...
BDSX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BDSX vs. KSRBF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSX is a Sell and KSRBF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BDSX: $1.35 vs. KSRBF: $0.27)
Brand notoriety: BDSX and KSRBF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BDSX: 171% vs. KSRBF: 100%
Market capitalization -- BDSX: $140.57M vs. KSRBF: $789.51M
BDSX [@Medical Specialties] is valued at $140.57M. KSRBF’s [@Medical Specialties] market capitalization is $789.51M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDSX’s FA Score shows that 0 FA rating(s) are green whileKSRBF’s FA Score has 2 green FA rating(s).

  • BDSX’s FA Score: 0 green, 5 red.
  • KSRBF’s FA Score: 2 green, 3 red.
According to our system of comparison, KSRBF is a better buy in the long-term than BDSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDSX’s TA Score shows that 5 TA indicator(s) are bullish.

  • BDSX’s TA Score: 5 bullish, 3 bearish.

Price Growth

BDSX (@Medical Specialties) experienced а -1.82% price change this week, while KSRBF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

BDSX is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KSRBF($790M) has a higher market cap than BDSX($141M). KSRBF YTD gains are higher at: 0.000 vs. BDSX (-26.902). KSRBF has higher annual earnings (EBITDA): 144M vs. BDSX (-37.1M). KSRBF has more cash in the bank: 2.03B vs. BDSX (26.3M). KSRBF has less debt than BDSX: KSRBF (43.1M) vs BDSX (60.7M). KSRBF has higher revenues than BDSX: KSRBF (1.85B) vs BDSX (49.1M).
BDSXKSRBFBDSX / KSRBF
Capitalization141M790M18%
EBITDA-37.1M144M-26%
Gain YTD-26.9020.000-
P/E RatioN/A92.59-
Revenue49.1M1.85B3%
Total Cash26.3M2.03B1%
Total Debt60.7M43.1M141%
TECHNICAL ANALYSIS
Technical Analysis
BDSX
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
BDSX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFCYX14.08-0.02
-0.14%
Columbia Flexible Capital Income Inst3
WCMAX13.22-0.16
-1.20%
WCM Mid Cap Quality Value Institutional
RTDYX20.09-0.26
-1.28%
Russell Inv Multifactor US Equity Y
BSCUX37.88-0.56
-1.46%
Baron Small Cap R6
QSMLX19.90-0.30
-1.49%
AQR Small Cap Multi-Style I

BDSX and

Correlation & Price change

A.I.dvisor tells us that BDSX and KSRBF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and KSRBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDSX
1D Price
Change %
BDSX100%
-3.93%
KSRBF - BDSX
26%
Poorly correlated
N/A
RVTY - BDSX
26%
Poorly correlated
-5.63%
ICAD - BDSX
24%
Poorly correlated
-8.12%
MYGN - BDSX
24%
Poorly correlated
-2.74%
VAPO - BDSX
24%
Poorly correlated
N/A
More

KSRBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KSRBF has been closely correlated with FLMNY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if KSRBF jumps, then FLMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KSRBF
1D Price
Change %
KSRBF100%
N/A
FLMNY - KSRBF
69%
Closely correlated
+0.12%
BDSX - KSRBF
26%
Poorly correlated
-3.93%
EDTXF - KSRBF
22%
Poorly correlated
-0.98%
NPCE - KSRBF
21%
Poorly correlated
-7.23%
IMTH - KSRBF
13%
Poorly correlated
N/A
More